CDIOW Stock Overview: Comprehensive Insights on Cardio Diagnostics Holdings, Inc. Shares

Stock Score/grades

The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company

Altman Z Score -6.53
Piotroski Score 4.00
Grade N/A

Company brief: Cardio Diagnostics Holdings, Inc. (CDIOW)

Sector Healthcare
Industry Biotechnology
CEO Dr. Meeshanthini V. Dogan Ph.D.
Website https://cardiodiagnosticsinc.com
Country US
Employees (FY) 7
Founded N/A
ISIN US14159C1119

Cardio Diagnostics Holdings, Inc. develops and commercializes epigenetics-based clinical tests for cardiovascular disease. It offers Epi+Gen CHD, a three-year symptomatic coronary heart disease risk assessment test. Cardio Diagnostics Holdings, Inc. was founded in 2017 and is based in Chicago, Illinois.

Price Target and Rating

Average Stock Price Target $0.00
High Stock Price Target $0.00
Low Stock Price Target $0.00
Potential Upside/Downside N/A
Consensus Rating Sell
Rating Score (0-4) N/A
Research Coverage N/A

Profitability

EPS (Most Recent Fiscal Year) $0.00
Trailing P/E Ratio N/A
Forward P/E Ratio N/A
P/E Growth N/A
Net Income $-8,376,834

Key Stats

Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.

Cardio Diagnostics Holdings, Inc. (CDIOW) Stock Price, News & Analysis

Stock Score/grades

Company brief: Cardio Diagnostics Holdings, Inc. (CDIOW)

Price Target and Rating

Profitability

Key Stats

Select an alert type

Setup alert

Log In

Email Verification

Welcome to StockNews!

Create Your Account

Email Verification